Back to search

Article

Resusceptibility to Ceftazidime-Avibactam in Tigecycline-Exposed NDM-Producing CRECC

2026-03-11

Abstract excerpt

<title>Abstract</title> <p> Purpose Carbapenem-resistant <italic>Enterobacter cloacae</italic> complex (CRECC) has become an increasingly important pathogen in healthcare-associated infections, with limited treatment options and a high mortality rate. As reports of antimicrobial resistance continue to rise, tigecycline (TGC) and ceftazidime-avibactam (CZA) have emerged as the last-line therapies for CRECC inf...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f375a752-ef90-53a3-9e30-0881f2801050
DOI
10.21203/rs.3.rs-8784943/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resusceptibility to Ceftazidime-Avibactam in Tigecycline-Exposed NDM-Producing CRECCDOI 10.21203/rs.3.rs-8784943/v1
Select a neighboring publication to make it the new centre.